INVO Fertility (IVF) EBITDA Margin (2011 - 2026)
INVO Fertility's (IVF) quarterly EBITDA Margin came in at 78.95% in Q1 2026, down 568.0% year-on-year from 16.87% in Q1 2025, and up 15.18% on a QoQ basis from 93.08% in Q3 2025.
INVO Fertility (IVF) EBITDA Margin (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of EBITDA Margin data on file, last reported at 78.95% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 568.0% year-over-year to 78.95% in Q1 2026; TTM through Mar 2026 was 101.96%, a 1660.0% increase from a year earlier, with the FY2024 full-year figure at 124.4%, up 9964.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 78.95%, up from 93.08% in the prior quarter.
- Over the last five years, EBITDA Margin for IVF reached as high as 73.27% in Q1 2025 and fell as low as 1835.17% in Q2 2022.
- Historically, EBITDA Margin has averaged 497.63% across 5 years, with a median of 134.81% in 2025.
- Across the five-year window, EBITDA Margin sank 143325 bps in 2022 and soared 118117 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 977.31% in 2022, then jumped by 89 bps to 109.17% in 2023, then plunged by 88 bps to 205.47% in 2024, then surged by 55 bps to 93.08% in 2025, then rose by 15 bps to 78.95% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 78.95% in Q1 2026, 93.08% in Q3 2025, and 160.44% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -78.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.95% |
| Sep 30, 2025 | -93.08% |
| Jun 30, 2025 | -160.44% |
| Mar 31, 2025 | -73.27% |
| Dec 31, 2024 | -205.47% |
| Sep 30, 2024 | -90.74% |
| Jun 30, 2024 | -100.89% |
| Mar 31, 2024 | -95.67% |
| Dec 31, 2023 | -109.17% |
| Sep 30, 2023 | -90.91% |
| Jun 30, 2023 | -653.99% |
| Mar 31, 2023 | -662.72% |
| Dec 31, 2022 | -977.31% |
| Sep 30, 2022 | -1,073.18% |
| Jun 30, 2022 | -1,835.17% |
| Mar 31, 2022 | -1,661.11% |
| Dec 31, 2021 | 16.52% |
| Sep 30, 2021 | -1,038.83% |
| Jun 30, 2021 | -904.95% |
| Mar 31, 2021 | -227.87% |